Targeting Abnormal Cell Metabolism Shows Promise for Treating Aggressive Pediatric Brain Tumors
Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA
Liver and Biliary Cancer Surgery Program Offers Multidisciplinary Care, Advanced Treatments
Proton Therapy Hypofractionation for Prostate CancerAn effective option that reduces the length of radiation treatment in a young patient with early-stage prostate cancer
An effective option that reduces the length of radiation treatment in a young patient with early-stage prostate cancer
Dana-Farber Cancer Institute Faculty Recognized as 2021 ASCO Leaders in Cancer Care
Critical Care Protocols and Teamwork Help Emory Kidney Transplant Program Meet Pandemic-Related Challenges
CD40 Drug Before Surgery Shows Promise in Early-stage Pancreatic Cancer
Enhancing Care for Thoracic Oncology Surgery Patients
Post-Pandemic Cancer Care Delivery: Recovery or Redesign?
Strategy for Overcoming Resistance to Immunotherapy Unleashes Power of Dendritic Cells
UCSF Offers Growing Options for Focal Therapy in Prostate Cancer
Dana-Farber Research Leads to Better Understanding of the Immune System in Kidney Cancer
COVID-19 Research: Differences in Infection Rates for Men and Women and a Potential Link to Prostate Cancer
Immunotherapy Combination Improves Outcomes in Advanced Kidney Cancer
Two Leading Organizations Come Together for Better Cancer Care
Showing 16 - 30 of 323 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...22 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
Dental
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Otolaryngology
Pulmonology
Surgery
Urology
person Sign In / Create Account
